Metformin Tablets

Cardio-Diabetic · Tablets / Extended-Release Tablets · 500mg / 850mg / 1000mg

Trade Information

Minimum Order Qty	1,000,000 tablets
Capacity	100 Million Tablets per month
Strength	500mg / 850mg / 1000mg
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Blister (Alu-Alu / Alu-PVC)
Strip pack
Bottle pack (HDPE)
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Metformin Hydrochloride
Dosage Form	Tablets / Extended-Release Tablets
Pack Size	10x10, Bottle of 100/500/1000 / Custom packing available
Storage	Store below 30°C in a dry place, protected from light and moisture
Shelf Life	24 months from date of manufacture

Description

Metformin is the first-line oral medicine for type 2 diabetes and one of the most widely prescribed medicines in the world. It is listed on the WHO Model List of Essential Medicines.

BioGalen manufactures Metformin in immediate-release tablets (500mg, 850mg, 1000mg) and sustained-release forms, plus a Metformin-Gliclazide combination. As a long-term medicine it represents steady, repeat-order demand and a priority for chronic-disease supply programmes across rising-diabetes African markets.

Mechanism of Action

Metformin is a biguanide that lowers blood glucose mainly by reducing hepatic glucose production (gluconeogenesis), and to a lesser extent by improving peripheral insulin sensitivity and reducing intestinal glucose absorption. It does not stimulate insulin secretion, so it carries a low risk of hypoglycaemia when used alone. This combination of efficacy, safety, and low cost underpins its position as the recommended first-line pharmacological treatment for type 2 diabetes.

Indications

Type 2 diabetes mellitus (first-line)
Type 2 diabetes in combination with other antidiabetics
Insulin resistance management (as directed)

Available Variants

Metformin Tablets 500mg
Metformin Extended-Release Tablets 850mg
Metformin Extended-Release Tablets 1000mg
Metformin Hydrochloride 500mg & Gliclazide 80mg Tablets

Frequently Asked Questions

What is Metformin used for?

Metformin is a biguanide and the recommended first-line oral treatment for type 2 diabetes, lowering blood glucose by reducing hepatic glucose production and improving insulin sensitivity. It is on essential medicines lists worldwide.

What strengths and forms of Metformin does BioGalen manufacture?

BioGalen manufactures Metformin in 500 mg, 850 mg, and 1000 mg immediate-release tablets and sustained-release forms, under WHO-GMP with CTD and ACTD dossiers available.

Does BioGalen supply Metformin for chronic-disease programmes?

Yes. BioGalen supplies Metformin to importers, distributors, government tenders, and chronic-disease health programmes across Africa, where diabetes prevalence is rising, with flexible packaging and private labelling.

Explore More

Interested in Metformin Tablets?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form